NASDAQ:OSUR OraSure Technologies (OSUR) Stock Price, News & Analysis $3.61 +0.32 (+9.73%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$3.62 +0.01 (+0.25%) As of 05/22/2026 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About OraSure Technologies Stock (NASDAQ:OSUR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OraSure Technologies alerts:Sign Up Key Stats Today's Range$3.29▼$3.6550-Day Range$2.90▼$3.6152-Week Range$2.08▼$3.82Volume930,644 shsAverage Volume663,710 shsMarket Capitalization$248.55 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingReduce Company Overview OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based diagnostic and medical device company specializing in the development, manufacture and commercialization of point-of-care and self-testing products. Founded in 1988, OraSure has built a portfolio of oral fluid and other non-invasive specimen collection technologies that support the detection of infectious diseases, drugs of abuse, and health and wellness biomarkers. The company’s flagship product, the OraQuick® rapid HIV test, was the first Food and Drug Administration–approved over-the-counter oral fluid test for the detection of HIV-1/2 antibodies. Beyond HIV screening, OraSure offers a suite of products that include the OraQuick® HCV Rapid Antibody Test for hepatitis C, oral fluid and blood-based drug of abuse tests under the Intercept® and OraSure® brands, and collection devices for DNA-based analysis in forensic and bio-sampling applications. More recently, OraSure has leveraged its collection and assay expertise to introduce COVID-19 antigen and antibody tests. Serving healthcare providers, public health agencies, clinical laboratories and consumers around the world, OraSure maintains regulatory clearances or approvals in key markets across North America, Europe and Asia. The company products are distributed through direct sales teams, strategic partnerships and third-party distributors, with a focus on expanding access to rapid, accurate diagnostics in both professional and at-home settings. OraSure Technologies is led by Chairman, President and Chief Executive Officer William Caragol, who has guided the company’s growth and diversification since joining in 2006. Under his leadership, OraSure continues to invest in research and development to advance non-invasive testing solutions and strengthen its position in the global diagnostic marketplace.AI Generated. May Contain Errors. Read More OraSure Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreOSUR MarketRank™: OraSure Technologies scored higher than 37% of companies evaluated by MarketBeat, and ranked 640th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingOraSure Technologies has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Downside RiskOraSure Technologies has a consensus price target of $3.00, representing about 16.9% downside from its current price of $3.61.Amount of Analyst CoverageOraSure Technologies has only been the subject of 1 research reports in the past 90 days.Read more about OraSure Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of OraSure Technologies is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OraSure Technologies is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOraSure Technologies has a P/B Ratio of 0.79. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about OraSure Technologies' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.36% of the float of OraSure Technologies has been sold short.Short Interest Ratio / Days to CoverOraSure Technologies has a short interest ratio ("days to cover") of 8.49.Change versus previous monthShort interest in OraSure Technologies has recently decreased by 6.67%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOraSure Technologies does not currently pay a dividend.Dividend GrowthOraSure Technologies does not have a long track record of dividend growth. News and Social Media2.6 / 5News SentimentN/A News SentimentOraSure Technologies has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for OraSure Technologies this week, compared to 2 articles on an average week.Search Interest6 people have searched for OSUR on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.MarketBeat Follows2 people have added OraSure Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership4.4 / 5Insider TradingAcquiring Shares Cluster Insider Buying3 insiders have purchased shares of OraSure Technologies in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $470,657.00 in company stock, which represents 0.1894% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, OraSure Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $470,657.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders3.90% of the stock of OraSure Technologies is held by insiders.Percentage Held by Institutions93.50% of the stock of OraSure Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about OraSure Technologies' insider trading history. Receive OSUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OraSure Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OSUR Stock News HeadlinesOraSure Technologies (NASDAQ:OSUR) Shares Cross Above Two Hundred Day Moving Average - Here's WhyMay 22 at 3:39 AM | americanbankingnews.comOraSure Technologies Independent Director Acquires 195% More StockMay 17, 2026 | finance.yahoo.comPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.May 24 at 1:00 AM | Porter & Company (Ad)Contrasting OraSure Technologies (NASDAQ:OSUR) and Bio-Rad Laboratories (NYSE:BIO)May 17, 2026 | americanbankingnews.comInsider Buying: OraSure Technologies (NASDAQ:OSUR) Director Purchases 25,000 Shares of StockMay 15, 2026 | insidertrades.comOraSure Technologies (OSUR) price target increased by 25.00% to 5.10May 14, 2026 | msn.comOraSure Technologies (NASDAQ:OSUR) Share Price Passes Above Two Hundred Day Moving Average - Here's WhyMay 14, 2026 | americanbankingnews.comOraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2026 Earnings Call TranscriptMay 8, 2026 | insidermonkey.comSee More Headlines OSUR Stock Analysis - Frequently Asked Questions How have OSUR shares performed this year? OraSure Technologies' stock was trading at $2.42 on January 1st, 2026. Since then, OSUR stock has increased by 49.2% and is now trading at $3.61. How were OraSure Technologies' earnings last quarter? OraSure Technologies, Inc. (NASDAQ:OSUR) issued its earnings results on Wednesday, February, 25th. The medical instruments supplier reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.02. The medical instruments supplier earned $26.76 million during the quarter, compared to analysts' expectations of $26.44 million. OraSure Technologies had a negative net margin of 66.42% and a negative trailing twelve-month return on equity of 18.57%. Read the conference call transcript. Is OraSure Technologies doing a stock buyback? OraSure Technologies' Board of Directors approved a stock repurchase program on Monday, March 24th 2025, which authorizes the company to repurchase $40,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 15.6% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's management believes its shares are undervalued. Who are OraSure Technologies' major shareholders? OraSure Technologies' top institutional investors include Altai Capital Management L.P. (5.25%), Dimensional Fund Advisors LP (3.92%), Renaissance Technologies LLC (3.03%) and Yorkville Advisors Global LP (0.92%). Insiders that own company stock include Manner Carrie Eglinton, Kenneth J Mcgrath, Kathleen Gallagher Weber, Steven Kyle Boyd and John P Kenny. View institutional ownership trends. How do I buy shares of OraSure Technologies? Shares of OSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of OraSure Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that OraSure Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Arista Networks (ANET), ServiceNow (NOW) and Adobe (ADBE). Company Calendar Last Earnings2/25/2026Today5/24/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 OSUR's financial health is in the Green zone, according to TradeSmith. OSUR has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:OSUR CIK1116463 Webwww.orasure.com Phone(610) 882-1820Fax610-882-1830Employees840Year FoundedN/APrice Target and Rating Average Price Target for OraSure Technologies$3.00 High Price Target$3.00 Low Price Target$3.00 Potential Upside/Downside-16.9%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($1.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$68.73 million Net Margins-66.42% Pretax Margin-62.24% Return on Equity-18.57% Return on Assets-15.71% Debt Debt-to-Equity RatioN/A Current Ratio5.46 Quick Ratio4.77 Sales & Book Value Annual Sales$115.02 million Price / Sales2.16 Cash FlowN/A Price / Cash FlowN/A Book Value$4.55 per share Price / Book0.79Miscellaneous Outstanding Shares68,850,000Free Float66,164,000Market Cap$248.55 million OptionableOptionable Beta0.89 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:OSUR) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersSpaceX controls two-thirds of all satellites - and it is about to go publicSpaceX is targeting an IPO on June 11th, with trading set to begin June 12th and the roadshow kicking off June...NXT Wave Research | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredThe worst mistake you can make with the SpaceX IPOThe $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OraSure Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OraSure Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
